Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mark1 | Rat | 1,1-dichloroethene | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of MARK1 mRNA | CTD | PMID:26682919 | Mark1 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Mark1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MARK1 mRNA | CTD | PMID:22206623 | Mark1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MARK1 mRNA | CTD | PMID:17942748 | Mark1 | Rat | 17beta-estradiol | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | Estradiol results in increased expression of MARK1 mRNA | CTD | PMID:19484750 | Mark1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MARK1 mRNA | CTD | PMID:17942748 | Mark1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MARK1 mRNA | CTD | PMID:33387578 | Mark1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MARK1 mRNA | CTD | PMID:34747641 | Mark1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Mark1 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | Fenretinide results in increased expression of MARK1 mRNA | CTD | PMID:28973697 | Mark1 | Rat | 5-aza-2'-deoxycytidine | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Decitabine results in increased expression of MARK1 mRNA | CTD | PMID:16367923 | Mark1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MARK1 mRNA | CTD | PMID:30047161 | Mark1 | Rat | 9-cis-retinoic acid | increases expression | EXP | | 6480464 | Alitretinoin results in increased expression of MARK1 mRNA | CTD | PMID:16648578 | Mark1 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MARK1 mRNA | CTD | PMID:31881176 | Mark1 | Rat | allethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... | CTD | PMID:34896426 | Mark1 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MARK1 mRNA | CTD | PMID:30047161 | Mark1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MARK1 mRNA | CTD | PMID:16483693 | Mark1 | Rat | antirheumatic drug | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MARK1 mRNA | CTD | PMID:24449571 | Mark1 | Rat | arsenite(3-) | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | arsenite results in decreased expression of MARK1 mRNA | CTD | PMID:23974009 | Mark1 | Rat | atrazine | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of MARK1 mRNA | CTD | PMID:22378314 | Mark1 | Rat | beta-lapachone | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of MARK1 mRNA | CTD | PMID:38218311 | Mark1 | Rat | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of MARK1 mRNA | CTD | PMID:16648578 | Mark1 | Rat | bisphenol A | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MARK1 mRNA | CTD | PMID:22576693 | Mark1 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Mark1 | Rat | bisphenol A | decreases expression | ISO | Mark1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MARK1 mRNA | CTD | PMID:32156529 | Mark1 | Rat | bisphenol A | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MARK1 mRNA | CTD | PMID:25594700 | Mark1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MARK1 mRNA | CTD | PMID:25181051|PMID:30816183 | Mark1 | Rat | bisphenol A | increases methylation | ISO | MARK1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of MARK1 gene | CTD | PMID:22576693|PMID:31601247 | Mark1 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Mark1 | Rat | cadmium atom | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MARK1 more ... | CTD | PMID:37325564 | Mark1 | Rat | cadmium dichloride | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MARK1 more ... | CTD | PMID:37325564 | Mark1 | Rat | carbon nanotube | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of MARK1 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Mark1 | Rat | CGP 52608 | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MARK1 gene] | CTD | PMID:28238834 | Mark1 | Rat | choline | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Mark1 | Rat | cisplatin | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of MARK1 mRNA | CTD | PMID:27392435 | Mark1 | Rat | cisplatin | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MARK1 mRNA | CTD | PMID:27392435 | Mark1 | Rat | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of MARK1 mRNA | CTD | PMID:20187946 | Mark1 | Rat | cyclosporin A | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MARK1 mRNA | CTD | PMID:20106945 | Mark1 | Rat | cyhalothrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... | CTD | PMID:34896426 | Mark1 | Rat | cypermethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... | CTD | PMID:34896426 | Mark1 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of MARK1 mRNA | CTD | PMID:21266533 | Mark1 | Rat | dibutyl phthalate | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARK1 protein | CTD | PMID:30218697 | Mark1 | Rat | doxorubicin | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MARK1 mRNA | CTD | PMID:29803840 | Mark1 | Rat | entinostat | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of MARK1 mRNA | CTD | PMID:27188386 | Mark1 | Rat | ethanol | affects splicing | ISO | Mark1 (Mus musculus) | 6480464 | Ethanol affects the splicing of MARK1 mRNA | CTD | PMID:30319688 | Mark1 | Rat | fenvalerate | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... | CTD | PMID:34896426 | Mark1 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of MARK1 mRNA | CTD | PMID:31881178 | Mark1 | Rat | folic acid | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Mark1 | Rat | FR900359 | affects phosphorylation | ISO | MARK1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of MARK1 protein | CTD | PMID:37730182 | Mark1 | Rat | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of MARK1 gene | CTD | PMID:35440735 | Mark1 | Rat | L-methionine | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... | CTD | PMID:20938992 | Mark1 | Rat | lipopolysaccharide | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of MARK1 mRNA | CTD | PMID:35811015 | Mark1 | Rat | lipopolysaccharide | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MARK1 mRNA] | CTD | PMID:35811015 | Mark1 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of MARK1 mRNA | CTD | PMID:30047161 | Mark1 | Rat | methylmercury chloride | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of MARK1 mRNA | CTD | PMID:28001369 | Mark1 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Mark1 | Rat | monobenzyl phthalate | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Mark1 | Rat | Monobutylphthalate | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Mark1 | Rat | monoethyl phthalate | multiple interactions | ISO | Mark1 (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Mark1 | Rat | nickel atom | affects expression | ISO | MARK1 (Homo sapiens) | 6480464 | Nickel affects the expression of MARK1 mRNA | CTD | PMID:14575637 | Mark1 | Rat | nickel atom | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Nickel results in decreased expression of MARK1 mRNA | CTD | PMID:25583101 | Mark1 | Rat | nickel atom | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of MARK1 mRNA] | CTD | PMID:14575637 | Mark1 | Rat | okadaic acid | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of MARK1 mRNA | CTD | PMID:38832940 | Mark1 | Rat | paracetamol | affects expression | ISO | Mark1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MARK1 mRNA | CTD | PMID:17562736 | Mark1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MARK1 mRNA | CTD | PMID:33387578 | Mark1 | Rat | phenylarsine oxide | increases activity | ISO | MARK1 (Homo sapiens) | 6480464 | oxophenylarsine results in increased activity of MARK1 protein | CTD | PMID:10737602 | Mark1 | Rat | phenylarsine oxide | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | [oxophenylarsine results in increased activity of MARK1 protein] which results in increased phosphorylation of MAPT more ... | CTD | PMID:10737602 | Mark1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | [Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of MARK1 protein | CTD | PMID:30218697 | Mark1 | Rat | potassium chromate | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of MARK1 mRNA | CTD | PMID:22714537 | Mark1 | Rat | pyrethrins | decreases expression | EXP | | 6480464 | Pyrethrins results in decreased expression of MARK1 protein | CTD | PMID:34896426 | Mark1 | Rat | rotenone | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | Rotenone results in increased expression of MARK1 mRNA | CTD | PMID:32937126 | Mark1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MARK1 mRNA] | CTD | PMID:35811015 | Mark1 | Rat | sodium arsenite | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MARK1 mRNA | CTD | PMID:38568856|PMID:39719251 | Mark1 | Rat | staurosporine | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | Staurosporine inhibits the reaction [oxophenylarsine results in increased activity of MARK1 protein] | CTD | PMID:10737602 | Mark1 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MARK1 mRNA | CTD | PMID:30047161 | Mark1 | Rat | sunitinib | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MARK1 mRNA | CTD | PMID:31533062 | Mark1 | Rat | tamoxifen | increases expression | ISO | Mark1 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of MARK1 mRNA | CTD | PMID:25123088 | Mark1 | Rat | tetrachloromethane | affects expression | ISO | Mark1 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of MARK1 mRNA | CTD | PMID:17484886 | Mark1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MARK1 mRNA | CTD | PMID:34492290 | Mark1 | Rat | trichostatin A | multiple interactions | ISO | MARK1 (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Nickel affects the expression of MARK1 mRNA] | CTD | PMID:14575637 | Mark1 | Rat | trichostatin A | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MARK1 mRNA | CTD | PMID:24935251 | Mark1 | Rat | valproic acid | decreases methylation | ISO | MARK1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MARK1 gene | CTD | PMID:29154799 | Mark1 | Rat | valproic acid | increases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MARK1 mRNA | CTD | PMID:23179753 | Mark1 | Rat | valproic acid | affects expression | ISO | MARK1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MARK1 mRNA | CTD | PMID:25979313 | Mark1 | Rat | valproic acid | decreases expression | ISO | MARK1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MARK1 mRNA | CTD | PMID:28001369 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















